Please check your internet connection and try again.
# Sodium Phosphate Enema
## Overview
Sodium phosphate enemas are hypertonic saline solutions that act as osmotic laxatives by drawing water into the colon, softening stool and promoting bowel evacuation. They are available as pre-mixed solutions for rectal administration.
## Primary Indications
* Bowel preparation for diagnostic procedures (e.g., colonoscopy, sigmoidoscopy).
* Bowel preparation for surgery.
* Treatment of constipation.
## Adult Dosing
* **Bowel Preparation:** Typically, a single 4.5 oz (133 mL) bottle administered rectally, as directed by the prescriber, often followed by clear liquids. The exact timing and regimen can vary based on the procedure.
* **Constipation:** One 2.25 oz (66 mL) bottle administered rectally as a single dose. May be repeated after 24 hours if necessary.
**Maximum Dose:** Do not exceed one 4.5 oz (133 mL) dose in 24 hours for bowel preparation, or one 2.25 oz (66 mL) dose in 24 hours for constipation.
## Pediatric Dosing
* **Ages 2 to 11 years:** One-half of the adult dose (e.g., one 2.25 oz (66 mL) bottle for bowel preparation; one 1.125 oz (33 mL) dose for constipation).
* **Under 2 years:** Use is generally not recommended due to increased risk of electrolyte disturbances. If used, it must be under strict medical supervision and with significant dose reduction, likely guided by specific institutional protocols. Dosing is not well-established and is highly individualized.
## Dose Adjustments
No specific dose adjustments are typically required for renal or hepatic impairment due to the limited systemic absorption when used as directed. However, caution is advised in patients with pre-existing renal or cardiac conditions.
## Contraindications
* Congestive heart failure.
* Severe renal impairment.
* Congenital or acquired megacolon.
* Intestinal obstruction or perforation.
* Appendicitis.
* Gastroenteritis.
* Rectal bleeding, especially if undiagnosed.
* Children under 2 years of age (unless under strict medical supervision).
* Patients on medications that affect renal function or electrolyte balance.
## Adverse Effects
* **Common:** Abdominal cramping, nausea, vomiting, bloating, rectal irritation.
* **Serious:**
* **Hyperphosphatemia:** Can lead to hypocalcemia, tetany, cardiac arrhythmias, and renal failure. Risk is increased with repeated use, in children, and in patients with renal impairment.
* **Hyponatremia:** Can lead to seizures and central nervous system depression.
* **Dehydration.**
* **Electrolyte imbalances:** Especially in children and patients with renal dysfunction.
* **Rare:** Ulcerations, perforation, avascular necrosis of the bowel.
## Key Drug Interactions
* **Diuretics:** Increased risk of electrolyte imbalance and dehydration.
* **ACE inhibitors and ARBs:** Increased risk of hyperkalemia.
* **NSAIDs:** May increase risk of renal impairment and electrolyte disturbances.
* **Other laxatives:** Avoid concomitant use of other stimulant laxatives.
## Monitoring
* **Electrolytes:** Particularly phosphate and calcium levels, especially in patients at risk for imbalance (children, elderly, renal impairment, repeated use).
* **Renal function:** Monitor BUN and creatinine, especially in at-risk patients.
* **Fluid status:** Assess for signs of dehydration.
## Clinical Pearls
* Administer the enema slowly and instruct the patient to retain it for the recommended duration (usually 5-15 minutes) to maximize efficacy.
* Ensure adequate hydration with clear liquids before and after administration, as recommended.
* This medication should not be used for chronic constipation due to the risk of electrolyte disturbances.
* The risk of serious adverse effects, including hyperphosphatemia and renal failure, is significant, particularly in pediatric patients and those with underlying renal disease. Close monitoring is crucial.
***
*Please verify the current prescribing information for the most up-to-date and comprehensive details regarding dosing, safety, and interactions.*
